Major depression
RecruitingA study to evaluate the effectiveness and safety of DT-101 in adults with major depressive disorder
- Disease:Major depression
- Substances:–
Poland- Participants:18–64 years · 65+ years
- Sponsor:Draig Therapeutics Limited
Rare diseases
Investigational molecules
Locations
Back to Poland9 clinical trials in Suchy Las, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
PolandThe busiest research cities in the country
What the registry says about research in the country
Innovative research exploring COMP360 therapy for patients with treatment-resistant depression, focusing on improving depressive symptoms through targeted psychological support interventions.
These trials aim to provide new hope for patients who haven't responded to conventional treatments.
Comprehensive studies evaluating NMRA-335140 and other novel compounds for treating major depressive disorder, with both short-term efficacy and long-term safety assessments.
Multiple approaches are being investigated to enhance treatment outcomes for MDD patients.
Specialized research examining aticaprant as an adjunctive therapy for patients with major depressive disorder complicated by moderate-to-severe anhedonia.
These trials specifically target the challenging subset of depression with prominent anhedonia symptoms.
Tell us about your condition – we search every trial in Europe and connect you with the right site.